Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q3495231> ?p ?o }
Showing triples 1 to 61 of
61
with 100 triples per page.
- Q3495231 subject Q5920511.
- Q3495231 subject Q6811985.
- Q3495231 subject Q8965786.
- Q3495231 subject Q9245110.
- Q3495231 abstract "Treprostinil (marketed under the trade names Remodulin for infusion and Tyvaso for inhalation) is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil is a synthetic analog of prostacyclin (PGI2).The inhaled form of treprostinil was approved by the FDA in July 2009 and is marketed as the trade name Tyvaso.The oral form of treprostinil was undergoing clinical trials.".
- Q3495231 atcPrefix "B01".
- Q3495231 atcSuffix "AC21".
- Q3495231 casNumber "289480-64-4".
- Q3495231 chEBI "50861".
- Q3495231 drugbank "DB00374".
- Q3495231 fdaUniiCode "RUM6K67ESG".
- Q3495231 iupacName "(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl]oxy]acetic acid".
- Q3495231 pubchem "6918140".
- Q3495231 thumbnail Treprostinil.svg?width=300.
- Q3495231 wikiPageWikiLink Q101026.
- Q3495231 wikiPageWikiLink Q10916362.
- Q3495231 wikiPageWikiLink Q1128595.
- Q3495231 wikiPageWikiLink Q1164665.
- Q3495231 wikiPageWikiLink Q14859627.
- Q3495231 wikiPageWikiLink Q152234.
- Q3495231 wikiPageWikiLink Q16252735.
- Q3495231 wikiPageWikiLink Q168800.
- Q3495231 wikiPageWikiLink Q190404.
- Q3495231 wikiPageWikiLink Q199602.
- Q3495231 wikiPageWikiLink Q200656.
- Q3495231 wikiPageWikiLink Q201035.
- Q3495231 wikiPageWikiLink Q209717.
- Q3495231 wikiPageWikiLink Q215118.
- Q3495231 wikiPageWikiLink Q275419.
- Q3495231 wikiPageWikiLink Q275792.
- Q3495231 wikiPageWikiLink Q30612.
- Q3495231 wikiPageWikiLink Q309971.
- Q3495231 wikiPageWikiLink Q326276.
- Q3495231 wikiPageWikiLink Q412050.
- Q3495231 wikiPageWikiLink Q421700.
- Q3495231 wikiPageWikiLink Q476921.
- Q3495231 wikiPageWikiLink Q485014.
- Q3495231 wikiPageWikiLink Q5920511.
- Q3495231 wikiPageWikiLink Q640448.
- Q3495231 wikiPageWikiLink Q6811985.
- Q3495231 wikiPageWikiLink Q86.
- Q3495231 wikiPageWikiLink Q8965786.
- Q3495231 wikiPageWikiLink Q901998.
- Q3495231 wikiPageWikiLink Q9245110.
- Q3495231 wikiPageWikiLink Q970208.
- Q3495231 atcPrefix "B01".
- Q3495231 atcSuffix "AC21".
- Q3495231 casNumber "289480".
- Q3495231 chebi "50861".
- Q3495231 drugbank "DB00374".
- Q3495231 iupacName "-233".
- Q3495231 pubchem "6918140".
- Q3495231 unii "RUM6K67ESG".
- Q3495231 type ChemicalSubstance.
- Q3495231 type Drug.
- Q3495231 type ChemicalObject.
- Q3495231 type Thing.
- Q3495231 type Q8386.
- Q3495231 comment "Treprostinil (marketed under the trade names Remodulin for infusion and Tyvaso for inhalation) is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil is a synthetic analog of prostacyclin (PGI2).The inhaled form of treprostinil was approved by the FDA in July 2009 and is marketed as the trade name Tyvaso.The oral form of treprostinil was undergoing clinical trials.".
- Q3495231 label "Treprostinil".
- Q3495231 depiction Treprostinil.svg.